Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0ZV0R
|
|||
| Former ID |
DIB001971
|
|||
| Drug Name |
F-200
|
|||
| Synonyms |
Eos-200-F; Anti-alpha-5/beta-1 integrin Ab Fragment, PDL; Anti-alpha-5/beta-1 integrin Fab, PDL; Anti-alpha-5/beta-1 integrin Fab, Protein Design Labs
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Ocular disease [ICD-11: N.A.] | Terminated | [1] | |
| Company |
Eos Biotechnology Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H18FN5OS
|
|||
| Canonical SMILES |
CC(C)NC1=NC=NC(=C1)C2=CSC(=N2)N(C)C(=O)C3=CC=C(C=C3)F
|
|||
| InChI |
1S/C18H18FN5OS/c1-11(2)22-16-8-14(20-10-21-16)15-9-26-18(23-15)24(3)17(25)12-4-6-13(19)7-5-12/h4-11H,1-3H3,(H,20,21,22)
|
|||
| InChIKey |
WIVGIKIKQHUFOD-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018439) | |||
| REF 2 | US patent application no. 8,541,413, Sustained release eye drop formulations. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.